Noninvasive Brain Stimulation to Enhance Reading Comprehension Ability in Adults
NCT ID: NCT05523505
Last Updated: 2025-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2022-11-07
2026-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurobiology and Treatment of Reading Disability in NF-1
NCT00624234
V5/MT Stimulation on Reading and Reading-related Measures in Developmental Dyslexia
NCT05972200
Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss
NCT07216924
Reading Problems Associated With Central Nervous System (CNS) Pathologies.
NCT04937725
Restoring Neural Oscillatory Communication in Developmental Dyslexia
NCT05583136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To accomplish this, the proposed study will invite typical adults with a range of RC ability (good and poor) to participate in three visits to the lab. The rationale for examining adults is to that the current study aims to develop a brain-based intervention (i.e. non-invasive brain stimulation) to treat low literacy in adults, as current behavioral interventions in adults are largely unsuccessful. N=100 participants will come in for three visits; for each visit adults will complete behavioral testing, magnet resonance imaging (MRI), and electroencephalography (EEG). Visit 1 will establish baseline behavior and brain measures of the individual (total visit time of 3.5 hours). Visit 2 will include a behavioral and safe, non-invasive stimulation intervention for the individual (total visit of 3 hours). Stimulation will involve two sessions, one while subjects are in the MRI, and one while subjects are having EEG. Visit 2 will also involve behavioral testing to determine intervention effects. Visit 3 will establish prolonged intervention effects using behavior and brain measures of the individual (total visit of 2.5 hours). Participants will be recruited and randomly assigned to receive one of three non-invasive stimulation interventions, and all will receive a canonical behavioral intervention, so that the smallest subgroup in the study will be N=30, which provides sufficient statistical power (see Statistical Design and Power). All subjects will have typical word reading ability (greater than or equal to 15th percentile), and either good (greater than 25th percentile) or poor (less than or equal to 25th percentile) reading comprehension ability. Non-invasive stimulation subgroups include two stimulation groups distinguished only by electrode placement, and one sham control group. Behavioral intervention involves a short paper/pencil reading comprehension intervention. Each intervention subgroup will be randomly assigned, but with the restriction that the distribution of reading comprehension ability is even across subgroups. This will be accomplished while maintaining double-blind procedures. Collection will begin in Summer 2022 and continue through Fall 2026. Adults will be recruited from the Nashville community. Behavioral testing and MRI (with and without stimulation) will occur at the Vanderbilt Institute for Imaging Science (VUIIS). EEG (with and without stimulation) will occur at the Vanderbilt Kennedy Center.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sham stimulation
Participants receiving sham stimulation.
Sham intervention
Use of the non-invasive brain stimulation device to simulate peripheral experience of stimulation without actually stimulating the brain.
Reading and Language Network (RLN)
Participants receiving real stimulation to the left angular gyrus.
RLN real non-invasive brain stimulation intervention
Real non-invasive brain stimulation to the left angular gyrus using transcranial alternating current stimulation (tACS).
RLN and CCN
Participants receiving real stimulation to the left dorsolateral prefrontal cortex and left angular gyrus.
RLN and CCN real non-invasive brain stimulation intervention
Real non-invasive brain stimulation to the left dorsolateral prefrontal cortex and left angular gyrus using transcranial alternating current stimulation (tACS).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sham intervention
Use of the non-invasive brain stimulation device to simulate peripheral experience of stimulation without actually stimulating the brain.
RLN real non-invasive brain stimulation intervention
Real non-invasive brain stimulation to the left angular gyrus using transcranial alternating current stimulation (tACS).
RLN and CCN real non-invasive brain stimulation intervention
Real non-invasive brain stimulation to the left dorsolateral prefrontal cortex and left angular gyrus using transcranial alternating current stimulation (tACS).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. known uncorrectable visual impairment;
3. documented hearing impairment greater than or equal to a 25 dB loss;
4. medical contraindication to MRI procedures (e.g., metal devices);
5. known IQ below 70;
6. a pervasive developmental disorder;
7. any known neurologic pathology, including epilepsy, spina bifida, cerebral palsy, traumatic brain injury, and brain tumors;
8. recent medical diagnosis of migraines;
9. pregnancy;
10. history of syncope;
11. severe fatigue,
12. bilingualism or low English proficiency;
13. poor reading ability that will prevent completion of the tasks; and
14. comorbid severe psychiatric disorders will be excluded;
15. a personal medical history of stroke or seizures;
16. hair styles that do not allow for proper EEG net fitting, or that pose potential risks for damage to EEG net
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
Vanderbilt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katherine Aboud
Research Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katherine S. Aboud, PhD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
220596
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.